TCRT - Alaunos Therapeutics Price to Earnings Adjusted for Growth Rate

Symbol and logo of brand Alaunos Therapeutics (TCRT)

The intellectual capital of Alaunos Therapeutics (TCRT) currently holds limited value due to a shift in business structure. Nevertheless, Alaunos Therapeutics (TCRT) aims to capture the oncology niche by scaling its Sleeping Beauty platform. The current P/E dynamics relative to GURU.Markets system growth contain data where 0.00 reflects the current volume of the metric. However, colossal sterile logistics costs and strict regulatory oversight are hindering development.

TCRT: Alaunos Therapeutics Inc. PEG Multiple 07/04/2022 - 11/12/2026

Metric breakdowns and analytics for Alaunos Therapeutics (TCRT)

- market value and analyst target forecast:
Price Rate Chart alaunos.com|TCRT - Consensus Target
- market capitalization statistics:
Market Value Alaunos|TCRT - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Accounting Value of a Share Alaunos Therapeutics|TCRT - Book Capitalization|Market Cap to Net Assets Ratio alaunos.com|TCRT - Company Total Assets
- business debt structure and liquidity details:
Debt to Capital Alaunos Therapeutics|TCRT - Long-Term Debt to Equity|Short-Term Debt to Equity alaunos.com|TCRT - Company Debts|Debt to Book Capitalization Ratio Alaunos|TCRT - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Alaunos Therapeutics|Critical Liquidity alaunos.com
- earnings and valuation multiples information:
TCRT - Net Profit|Expected Net Profit Alaunos Therapeutics|TCRT - Price to Earnings Ratio|Price to Future Earnings Ratio alaunos.com|TCRT - PEG Multiple|Company Value to EBITDA Alaunos|TCRT - Operating profit before deduction of amortization|Earnings per share for the trailing year Alaunos Therapeutics|TCRT - Net earnings per share for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months alaunos.com|TCRT - Earnings growth in current year|Expected earnings per share trend next year Alaunos Therapeutics
Fundamental company analysis:Alaunos Therapeutics Inc. TCRT
Mass-produced product of alaunos.com

The price action of Alaunos Therapeutics (TCRT) on the PEG growth stock filter reflects a critical correlation between market valuation and earnings growth rates. This indicator compares the P/E ratio to the EPS growth rate, where a value below one indicates an undervalued asset, which, amid pipeline restructuring and liquidity shortages, serves as a signal for Alaunos Therapeutics (TCRT) regarding a potential reversal or liquidation risk.

Who Alaunos Therapeutics competes with

Legend Biotech Corp (LEGN) - Price to Net Income Growth Ratio|Sana Bio - Price/Earnings to Growth Multiple|Autolus Corp (AUTL) - Price to Earnings Adjusted for Growth Rate|ALLO: Price/Earnings to Growth Multiple|Growth-Adjusted Payback Ratio RNAC (selectabio.com)|CLLS: PEG Multiple|Price/Earnings to Growth Multiple Caribou Biosciences Inc.|TIL (Instil Bio, Inc) - PEG Multiple|Price to Earnings Adjusted for Growth Rate Genenta GNTA|Price/Earnings to Growth Ratio Century Therapeutics (IPSC)|Price/Earnings to Growth Ratio JSPR (jaspertherapeutics.com)|Price/Earnings to Growth Ratio Senti Biosciences SNTI|Adaptimmune Therapeutics plc - Price/Earnings to Growth Ratio|CERO: Price/Earnings to Growth Multiple|Growth-Adjusted Payback Ratio ACHL (Achilles Therapeutics)|CRGX: PEG Multiple|Price to Net Income Growth Ratio poseida.com PSTX|TSVT (2seventy bio) - PEG Multiple|Price to Earnings Adjusted for Growth Rate Gracell Bio GRCL